Synaptotagmin, GAP1, and centaurin-alpha inositol phosphate–binding domains (IP4-binding domains)

The Synaptotagmin, GAP1, and centaurin-alpha inositol phosphate–binding domains refer to a specialized group of protein domains—specifically the C2B domain of Synaptotagmin and the Pleckstrin Homology (PH) domains of GAP1 (RASA3) and Centaurin-alpha (ADAP1)—that function as high-affinity receptors for the second messenger inositol 1,3,4,5-tetraphosphate (Ins(1,3,4,5)P4). These domains play a pivotal role in cellular signaling by translating changes in inositol phosphate levels into downstream physiological responses. In the nervous system, Synaptotagmin-1 uses its C2B domain to bind IP4, which can competitively inhibit calcium-dependent vesicle fusion and neurotransmitter release. In other tissues, the PH domains of GAP1 and Centaurin-alpha mediate their recruitment to the plasma membrane, where they act as GTPase-activating proteins (GAPs) for Ras and Arf, respectively, thereby regulating cell growth, differentiation, and membrane trafficking. While no FDA-approved drugs currently target these domains directly, they are of significant interest in the development of therapies for neurodegenerative diseases, cancer, and thrombosis, where dysregulation of inositol phosphate signaling is implicated.

Other names

Inositol 1,3,4,5-tetraphosphate-binding domainsIP4-binding domainsC2B domain (Synaptotagmin)PH domain (GAP1/Centaurin-alpha)Ins(1,3,4,5)P4 receptorsIP4BPp42IP4Ras GTPase-activating protein 3 (RASA3)Arf-GAP with dual PH domain-containing protein 1 (ADAP1)Synaptotagmin-1 (SYT1)

Competitive binding to inositol phosphate-binding sites, modulation of GTPase activity, and regulation of calcium-dependent vesicle fusion.